U.S. Intraocular Lens Market Size & Outlook, 2022-2030

The intraocular lens market in the United States is expected to reach a projected revenue of US$ 1,808.0 million by 2030. A compound annual growth rate of 4.9% is expected of the United States intraocular lens market from 2023 to 2030.
Revenue, 2022 (US$M)
$1,236.8
Forecast, 2030 (US$M)
$1,808.0
CAGR, 2023 - 2030
4.9%
Report Coverage
U.S.

U.S. intraocular lens market highlights

  • The U.S. intraocular lens market generated a revenue of USD 1,236.8 million in 2022 and is expected to reach USD 1,808.0 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 4.9% from 2023 to 2030.
  • In terms of segment, multifocal intraocular lenses was the largest revenue generating product in 2022.
  • Toric Intraocular Lenses is the most lucrative product segment registering the fastest growth during the forecast period.


Intraocular lens market data book summary

Market revenue in 2022USD 1,236.8 million
Market revenue in 2030USD 1,808.0 million
Growth rate4.9% (CAGR from 2022 to 2030)
Largest segmentMultifocal intraocular lenses
Fastest growing segmentToric Intraocular Lenses
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationMonofocal Intraocular Lenses, Multifocal Intraocular Lenses, Toric Intraocular Lenses, Accommodative Intraocular Lenses
Key market players worldwideAlcon Inc, Bausch & Lomb Corp, Carl Zeiss Meditec AG, Staar Surgical Co, Hoya Corp, Johnson & Johnson, Rayner Surgical Group, Eyekon Medical, Lenstec, HumanOptics


Other key industry trends

  • In terms of revenue, U.S. accounted for 29.2% of the global intraocular lens market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. intraocular lens market is projected to lead the regional market in terms of revenue in 2030.
  • U.S. is the fastest growing regional market in North America and is projected to reach USD 1,808.0 million by 2030.

Multifocal intraocular lenses was the largest segment with a revenue share of 57.13% in 2022. Horizon Databook has segmented the U.S. intraocular lens market based on monofocal intraocular lenses, multifocal intraocular lenses, toric intraocular lenses, accommodative intraocular lenses covering the revenue growth of each sub-segment from 2018 to 2030.


The U.S. intraocular lenses market was valued at USD 1,064.6 million in 2017. The U.S. market is driven majorly by factors such as rising geriatric population and favorable reimbursement policies. The number of cataract cases reported in the region is high. 

According to American Academy of Ophthalmology, 2 million cataract surgeries are performed each year in the U.S. It also reported that in 2014, nearly 24.5 million people suffered from cataract in the U.S. Growing incidence of cataract is expected to directly impact the market as intraocular lenses are an integral part of majority of cataract surgeries. 

According to Novartis annual report 2015, each year around 4 million cataract surgeries are performed in the U.S. The procedural volume is expected to increase with growing geriatric population as elderly people are more susceptible to cataract. 

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Intraocular Lens Market Companies

Name Profile # Employees HQ Website

U.S. intraocular lens market size, by product, 2018-2030 (US$M)

U.S. Intraocular Lens Market Outlook Share, 2022 & 2030 (US$M)

U.S. intraocular lens market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more